T. J. Opgenorth

2.3k total citations · 2 hit papers
32 papers, 1.9k citations indexed

About

T. J. Opgenorth is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Nephrology. According to data from OpenAlex, T. J. Opgenorth has authored 32 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 12 papers in Physiology and 7 papers in Nephrology. Recurrent topics in T. J. Opgenorth's work include Nitric Oxide and Endothelin Effects (11 papers), Heart Failure Treatment and Management (9 papers) and Renin-Angiotensin System Studies (7 papers). T. J. Opgenorth is often cited by papers focused on Nitric Oxide and Endothelin Effects (11 papers), Heart Failure Treatment and Management (9 papers) and Renin-Angiotensin System Studies (7 papers). T. J. Opgenorth collaborates with scholars based in United States and United Kingdom. T. J. Opgenorth's co-authors include J. P. Granger, John C. Burnett, J. C. Burnett, Denise M. Heublein, Pei-Chun Kao, G. S. Reeder, David M. Pollock, Barbara J. Divish, Jinshyun R. Wu‐Wong and William J. Chiou and has published in prestigious journals such as Science, Biochemical and Biophysical Research Communications and Kidney International.

In The Last Decade

T. J. Opgenorth

31 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Atrial Natriuretic Peptide Elevation in Congestive Heart Failure in the Human

1986 732 citations J. C. Burnett, J. P. Granger et al. profile →
Effects of synthetic atrial natriuretic factor on renal function and renin release

1984 448 citations John C. Burnett, J. P. Granger et al. American Journal of Physiology-Renal Physiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T. J. Opgenorth United States	16	1.4k	451	400	336	241	32	1.9k
P. A. Poole‐Wilson United Kingdom	24	1.6k 1.1×	622 1.4×	668 1.7×	299 0.9×	340 1.4×	70	2.8k
J. C. Burnett United States	27	1.8k 1.3×	630 1.4×	624 1.6×	443 1.3×	264 1.1×	53	2.8k
Muneya Suzuki United States	9	764 0.6×	433 1.0×	174 0.4×	237 0.7×	144 0.6×	18	1.3k
T. Takeda Japan	24	728 0.5×	503 1.1×	618 1.5×	234 0.7×	197 0.8×	70	1.9k
S Umemura Japan	22	553 0.4×	467 1.0×	219 0.5×	182 0.5×	331 1.4×	86	1.5k
Sharon M. Sandberg United States	19	1.2k 0.9×	374 0.8×	648 1.6×	260 0.8×	151 0.6×	31	1.8k
Shin‐ichi Suga Japan	22	728 0.5×	473 1.0×	197 0.5×	252 0.8×	212 0.9×	37	1.7k
Jerry L. Wessale United States	19	585 0.4×	387 0.9×	740 1.9×	383 1.1×	128 0.5×	57	1.6k
Céline Fassot France	21	1.3k 1.0×	342 0.8×	215 0.5×	436 1.3×	383 1.6×	42	2.3k
Lisa C. Costello‐Boerrigter United States	24	1.7k 1.2×	451 1.0×	197 0.5×	539 1.6×	220 0.9×	59	2.3k

Countries citing papers authored by T. J. Opgenorth

Since Specialization

Citations

This map shows the geographic impact of T. J. Opgenorth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. J. Opgenorth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. J. Opgenorth more than expected).

Fields of papers citing papers by T. J. Opgenorth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. J. Opgenorth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. J. Opgenorth. The network helps show where T. J. Opgenorth may publish in the future.

Co-authorship network of co-authors of T. J. Opgenorth

This figure shows the co-authorship network connecting the top 25 collaborators of T. J. Opgenorth. A scholar is included among the top collaborators of T. J. Opgenorth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. J. Opgenorth. T. J. Opgenorth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chiou, William J., et al.. (2000). ‘Irreversible’ Endothelin-1 Binding Does Not Prohibit ABT-627 From Reversing Endothelin-1-Induced Effects. Journal of Cardiovascular Pharmacology. 36(Supplement 1). S48–S52. 12 indexed citations

Pollock, David M., James S. Polakowski, T. J. Opgenorth, & Jennifer S. Pollock. (1998). Role of endothelin ETA receptors in the hypertension produced by 4-day l-nitroarginine methyl ester and cyclosporine treatment. European Journal of Pharmacology. 346(1). 43–50. 18 indexed citations

Pollock, David M., James S. Polakowski, Craig D. Wegner, & T. J. Opgenorth. (1997). Beneficial Effect of ET_AReceptor Blockade in a Rat Model of Radiocontrast-Induced Nephropathy. Renal Failure. 19(6). 753–761. 34 indexed citations

Wilkins, F. C., Antonio Alberola, H. L. Mizelle, T. J. Opgenorth, & Joey P. Granger. (1995). Systemic hemodynamics and renal function during long-term pathophysiological increases in circulating endothelin. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 268(2). R375–R381. 42 indexed citations

Surber, Bruce W., Samuel Thomas, Andrew S. Tasker, et al.. (1994). [3H]A-81988, a potent, selective, competitive antagonist radioligand for angiotensin AT1 receptors. European Journal of Pharmacology Molecular Pharmacology. 267(1). 49–54. 3 indexed citations

Buckner, Steven A., Robert B. Warner, Martin Winn, et al.. (1994). Characterization of antihypertensive activity of ABBOTT-81988, a nonpeptide angiotensin II antagonist in the renal hypertensive rat.. Journal of Pharmacology and Experimental Therapeutics. 268(1). 427–433. 6 indexed citations

Pollock, David M., et al.. (1993). Angiotensin II receptor blockade improves renal function in rats with reduced renal mass.. Journal of Pharmacology and Experimental Therapeutics. 267(2). 657–663. 37 indexed citations

Pollock, David M. & T. J. Opgenorth. (1993). Atrial Natriuretic Peptides in the Treatment of Acute Renal Failure. Renal Failure. 15(4). 439–449.

Wu‐Wong, Jinshyun R., William J. Chiou, & T. J. Opgenorth. (1993). Phosphoramidon modulates the number of endothelin receptors in cultured Swiss 3T3 fibroblasts.. Molecular Pharmacology. 44(2). 422–429. 14 indexed citations

10.

Warner, Robert B., Martin Winn, Thomas M. Zydowsky, et al.. (1993). Antihypertensive Activity of ABBOTT-81282, a Nonpeptide Angiotensin II Antagonist, in the Renal Hypertensive Rat. Pharmacology. 47(3). 176–187. 7 indexed citations

11.

Pollock, David M. & T. J. Opgenorth. (1992). Beneficial Effect of the ANF Analog A68828 on Recovery from Ischemic Acute Renal Failure. Renal Failure. 14(2). 141–146. 6 indexed citations

12.

Pollock, David M., et al.. (1991). Effect of the ANF analog A68828 in cisplatin-induced acute renal failure.. Journal of Pharmacology and Experimental Therapeutics. 257(3). 1179–1183. 4 indexed citations

13.

Holleman, William H., Gerald P. Budzik, David M. Pollock, et al.. (1991). Truncated atrial natriuretic factor analogs retain full agonist activity. Canadian Journal of Physiology and Pharmacology. 69(10). 1622–1627. 3 indexed citations

14.

Opgenorth, T. J., et al.. (1990). Atrial peptides induce mast cell histamine release. Peptides. 11(5). 1003–1007. 21 indexed citations

15.

Geldern, Thomas W von, Gerald P. Budzik, William H. Holleman, et al.. (1990). Atrial natriuretic peptide antagonists: biological evaluation and structural correlations.. Molecular Pharmacology. 38(6). 771–778. 33 indexed citations

16.

Pollock, David M. & T. J. Opgenorth. (1990). Beneficial effect of the atrial natriuretic factor analog A68828 in postischemic acute renal failure.. Journal of Pharmacology and Experimental Therapeutics. 255(3). 1166–1169. 11 indexed citations

17.

Opgenorth, T. J., Ryan Ferguson, & Clarence E. Grim. (1988). A familial risk of chronic renal failure among blacks on dialysis. Kidney International. 33(1). 204. 9 indexed citations

18.

Salazar, F. Javier, M. J. Fiksen-Olsen, T. J. Opgenorth, et al.. (1986). Renal effects of ANP without changes in glomerular filtration rate and blood pressure. American Journal of Physiology-Renal Physiology. 251(3). F532–F536. 54 indexed citations

19.

Opgenorth, T. J., et al.. (1986). Effects of atrial natriuretic peptide on renin secretion in nonfiltering kidney. American Journal of Physiology-Renal Physiology. 250(5). F798–F801. 44 indexed citations

20.

Burnett, John C., J. P. Granger, & T. J. Opgenorth. (1984). Effects of synthetic atrial natriuretic factor on renal function and renin release. American Journal of Physiology-Renal Physiology. 247(5). F863–F866. 448 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact